ReviewCurrent hematologic malignancy reports2021

Secondary AML Emerging After Therapy with Hypomethylating Agents: Outcomes, Prognostic Factors, and Treatment Options.

Daniel R Richardson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.